Tuesday - December 30, 2025
UTMB Health Designated as First Qualified Treatment Center in Texas for Zevaskyn
December 23, 2025
GALVESTON, Texas, Dec. 23 -- The University of Texas Medical Branch issued the following news release:

* * *

UTMB Health Designated as First Qualified Treatment Center in Texas for Zevaskyn

Cell and gene therapy is a treatment for ultra-rare dermatologic disease, recessive dystrophic epidermolysis bullosa (RDEB)

By Stephen Hadley

The University of Texas Medical Branch (UTMB Health) has advanced to become the fourth Qualified Treatm . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products